Upgrade to SI Premium - Free Trial

Synacor (SYNC)

2.19 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Activism

Latest Headlines

Beacon Therapeutics reports positive 12-month data for XLRP gene therapy May 7, 2026 3:00 PM - StreetInsider Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting May 7, 2026 3:00 PM - Globe NewsWire Beacon Therapeutics Annouces Presentations at the ARVO 2026 Annual Meeting April 29, 2026 8:00 AM - Globe NewsWire Full Article List